[144] Cellebrite DI Ltd. Warrants SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Cellebrite DI Ltd. (CLBTW) reports a proposed sale of 12,878 common shares valued at $225,743.61 to be executed through Morgan Stanley Smith Barney LLC on 09/11/2025 on NASDAQ. The shares were acquired on 09/11/2025 by exercise of options under a registered plan and payment was for services rendered. The filing shows 244,469,106 shares outstanding, and indicates no securities sold by the filer in the past three months. The filer certifies they are not aware of undisclosed material adverse information.

Positive

• Transaction executed under a registered plan, indicating procedural compliance with securities rules
• Broker-dealer identified (Morgan Stanley Smith Barney LLC), providing clear execution channel

Negative

• Insider sale of 12,878 shares valued at $225,743.61, which may be viewed negatively by some investors
• Filing lacks identity of the selling person and plan adoption date, limiting transparency about motivations

Insights

Securities Analyst

TL;DR: Insiders plan a routine post-exercise sale of a modest block of shares through a broker; not evidently material to capitalization.

The filing discloses a single proposed sale of 12,878 common shares following option exercise under a registered plan, executed through Morgan Stanley Smith Barney LLC on the stated date. The aggregate value is $225,743.61. Given the stated outstanding share count of 244,469,106, this block represents a small fraction of total equity. No disposals in the prior three months are reported. The filing follows Rule 144 procedures and includes the standard representation about undisclosed material information.

Corporate Governance Expert

TL;DR: Disclosure is procedurally compliant; the sale stems from option exercise and includes the required attestation by the seller.

The notice identifies the relationship to the issuer only through the exercise event; it documents acquisition date, nature of acquisition, consideration, and broker details consistent with Rule 144 requirements. The attestation regarding absence of undisclosed material information is present. The filing does not provide additional contextual details such as holder identity or plan adoption date, limiting governance assessment beyond procedural compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12878	225743.61	244469106	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Exercise of options under a registered plan	Issuer			12878	09/11/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 from CLBTW disclose?

It discloses a proposed sale of 12,878 common shares valued at $225,743.61 to be sold on 09/11/2025 through Morgan Stanley Smith Barney LLC on NASDAQ.

How were the shares acquired according to the filing?

The shares were acquired on 09/11/2025 by exercise of options under a registered plan, with payment noted as services rendered.

Does the filing report other sales by the same person in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

How large is the proposed sale relative to outstanding shares?

The filing lists 244,469,106 shares outstanding; the proposed sale of 12,878 shares is a small fraction of that total based on the disclosed numbers.

Does the filer attest to the existence of material undisclosed information?

Yes. The filer signs a representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.